465 related articles for article (PubMed ID: 21247518)
21. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study.
Potpara TS; Stankovic GR; Beleslin BD; Polovina MM; Marinkovic JM; Ostojic MC; Lip GYH
Chest; 2012 Feb; 141(2):339-347. PubMed ID: 21622553
[TBL] [Abstract][Full Text] [Related]
22. Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome.
Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
Cardiology; 2010; 115(3):200-4. PubMed ID: 20160440
[TBL] [Abstract][Full Text] [Related]
23. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
Roldán V; Marín F; Fernández H; Manzano-Fernández S; Gallego P; Valdés M; Vicente V; Lip GY
Am J Cardiol; 2013 Apr; 111(8):1159-64. PubMed ID: 23337836
[TBL] [Abstract][Full Text] [Related]
24. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up.
Scardi S; Mazzone C; Pandullo C; Goldstein D; Di Lenarda A; Chersevani D
G Ital Cardiol; 1999 Jun; 29(6):637-46. PubMed ID: 10396667
[TBL] [Abstract][Full Text] [Related]
25. Ischaemic cardiovascular mortality in patients with non-valvular atrial fibrillation according to CHADS₂ score.
Kim YD; Cha MJ; Kim J; Lee DH; Lee HS; Nam CM; Nam HS; Heo JH
Thromb Haemost; 2011 Apr; 105(4):712-20. PubMed ID: 21301786
[TBL] [Abstract][Full Text] [Related]
26. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
27. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
28. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
Palmer SC; Yandle TG; Frampton CM; Troughton RW; Nicholls MG; Richards AM
Eur Heart J; 2009 Jun; 30(12):1486-94. PubMed ID: 19389787
[TBL] [Abstract][Full Text] [Related]
29. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
[TBL] [Abstract][Full Text] [Related]
30. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
Chao TF; Lin YJ; Tsao HM; Tsai CF; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Ambrose K; Wu TJ; Chen SA
J Am Coll Cardiol; 2011 Nov; 58(23):2380-5. PubMed ID: 22115643
[TBL] [Abstract][Full Text] [Related]
31. CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
Koga M; Kimura K; Shibazaki K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Naganuma M; Nezu T; Maeda K; Minematsu K; Toyoda K
J Neurol Sci; 2011 Jul; 306(1-2):49-53. PubMed ID: 21492878
[TBL] [Abstract][Full Text] [Related]
32. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
33. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation.
Khumri TM; Idupulapati M; Rader VJ; Nayyar S; Stoner CN; Main ML
Am J Cardiol; 2007 Jun; 99(12):1733-6. PubMed ID: 17560884
[TBL] [Abstract][Full Text] [Related]
34. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].
Guize L; Thomas F; Bean K; Benetos A; Pannier B
Bull Acad Natl Med; 2007; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434
[TBL] [Abstract][Full Text] [Related]
35. Age dependent impact of estimated glomerular filtration rate on long-term survival after ischaemic stroke.
Lima HN; Cabral NL; Franklin J; Moro CH; Pecoits-Filho R; Gonçalves AR
Nephrology (Carlton); 2012 Nov; 17(8):725-32. PubMed ID: 22804798
[TBL] [Abstract][Full Text] [Related]
36. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
Jover E; Roldán V; Gallego P; Hernández-Romero D; Valdés M; Vicente V; Lip GY; Marín F
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):627-33. PubMed ID: 22609214
[TBL] [Abstract][Full Text] [Related]
38. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
39. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
[TBL] [Abstract][Full Text] [Related]
40. Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation.
Ho KW; Ivanov J; Freixa X; Overgaard CB; Osten MD; Ing D; Horlick E; Mackie K; Seidelin PH; Džavík V
Can J Cardiol; 2013 Feb; 29(2):213-8. PubMed ID: 23089528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
